Lilly Bamlanivimab Antibody Playbook
This antibody playbook provides information for state, territorial and local public health programs to plan and operationalize a bamlanivimab antibody response to COVID-19. The sections of this document cover specific areas of COVID-19 antibody program planning and implementation, as well as links to resources to assist with those efforts.
Related Content
The Transforming Power of Sickle Cell Gene Therapy (and Why Access Is Important)
Ensuring Access to Critical Medicines for Children
Reinforcing Readiness: Collaborating to End Drug Shortages
The Transforming Power of Sickle Cell Gene Therapy (and Why Access Is Important)
A revolutionary therapy takes some children’s lives to new heights. Others are left out.
Ensuring Access to Critical Medicines for Children
Discover how Angels for Change partners with manufacturers to prevent shortages and keep lifesaving pediatric drugs available.
Reinforcing Readiness: Collaborating to End Drug Shortages
Learn why the Children’s Hospital Association partners with a nonprofit to ensure medications are always available to patients who depend on them.
